Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1981 -0.0009 (-0.45%)
Streaming Delayed Price Updated: 11:43 AM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,673,434
Open 0.2011
Bid (Size) 0.1981 (1)
Ask (Size) 0.1991 (54)
Prev. Close 0.1990
Today's Range 0.1960 - 0.2011
52wk Range 0.1500 - 0.4100
Shares Outstanding 979,949,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference
Via ACCESSWIRE
The 7 Most Promising Penny Stocks to Buy in May 2023
Although extremely low-priced securities often present high risk, these are the most promising penny stocks to buy in May. 
Via InvestorPlace

Performance

YTD
+23.50%
+23.50%
1 Month
-0.95%
-0.95%
3 Month
-19.14%
-19.14%
6 Month
-2.51%
-2.51%
1 Year
-19.11%
-19.11%

More News

Read More
Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
Via ACCESSWIRE
Zomedica Exercises Option to Acquire Structured Monitoring Products
Via ACCESSWIRE
Zomedica to Host First Quarter Financial Results Call on May 11
Via ACCESSWIRE
Why Shares of Zomedica Were Zooming Monday
Via The Motley Fool
Earnings Scheduled For May 11, 2023
Via Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
Via InvestorPlace
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
7 Best Penny Stocks Under $3 to Buy in April
Via InvestorPlace
Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Zomedica Appoints New Chief Financial Officer
Via ACCESSWIRE
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
Via ACCESSWIRE
Earnings Scheduled For March 15, 2023
Via Benzinga
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
Via ACCESSWIRE
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
Via ACCESSWIRE
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
Via ACCESSWIRE
Zomedica to Participate in the Lytham Partners Investor Select Conference
Via ACCESSWIRE
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News
Via InvestorPlace
Why Is Zomedica (ZOM) Stock Up Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
Via ACCESSWIRE
Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Via ACCESSWIRE
Zomedica to Present at Sidoti Virtual Investor Conference January 18-19
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.